Related Experiment Video
Updated: Jul 18, 2026

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model
Published on: March 18, 2019
Cell-based approaches for cardiac repair
Michael Rubart1, Loren J Field
1Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 1044 West Walnut Street, RM W376, Indianapolis, IN 46202, USA.
Insights
Cardiovascular disease causes heart cell loss, diminishing function. This review explores new therapies like cell therapy and cell cycle activation to regenerate heart muscle cells and restore cardiac function.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Cardiac Physiology
Background:
- Cardiovascular diseases frequently lead to cardiomyocyte (heart muscle cell) loss through necrosis and apoptosis.
- The progressive depletion of contractile cells impairs overall cardiac function.
- Current research focuses on strategies to prevent cell death or regenerate lost cardiomyocytes.
Purpose of the Study:
- To review and discuss the current state of interventions aimed at repopulating the heart with new, functional cardiomyocytes.
- To evaluate the potential of various cell-based and cell cycle activation therapies for cardiac repair.
Main Methods:
- Literature review of existing research on cardiomyocyte loss and regeneration strategies.
- Analysis of cell therapy approaches, including cardiomyocyte cell therapy and myogenic stem cell therapy.
- Examination of cell cycle activation therapy as a method for endogenous cardiomyocyte proliferation.
Main Results:
- Multiple therapeutic avenues are being explored to address cardiomyocyte loss in cardiovascular disease.
- Strategies focus on either reducing cell death or replacing lost cells with newly generated cardiomyocytes.
- The integration of de novo cardiomyocytes into the existing cardiac syncytium is a key challenge.
Conclusions:
- Regenerating functional cardiomyocytes is crucial for improving cardiac function after injury.
- Cell therapy and cell cycle activation represent promising, yet challenging, approaches.
- Further research is needed to ensure the successful integration and long-term function of regenerated cardiomyocytes.
Abstract:
Many forms of cardiovascular disease are associated with cardiomyocyte loss via necrosis and/or apoptosis. The cumulative loss of contractile cells ultimately results in diminished cardiac function. Numerous approaches have been employed to reduce the rate of cardiomyocyte loss, or alternatively, to repopulate the heart with new cardiomyocytes. Strategies aimed at repopulating the heart include cardiomyocyte cell therapy, myogenic stem cell therapy, and cell cycle activation therapy. All three approaches are based on the assumption that the de novo cardiomyocytes will participate in a functional syncytium with the surviving myocardium. This review will discuss the current status of interventions aimed at repopulating the heart with functional cardiomyocytes.

